XML 57 R46.htm IDEA: XBRL DOCUMENT v3.25.2
Commitments and Contingencies - License Agreement (Details) - USD ($)
 1 Months Ended 6 Months Ended
Nov. 30, 2020
Oct. 31, 2020
Nov. 30, 2018
Jun. 30, 2025
Dec. 31, 2024
Commitments and Contingencies.          
One-time non-refundable fee of license agreement     $ 50,000    
Reimbursement of licensor's patent costs at execution of the license     145,000    
Minimum annual license fee     $ 25,000    
Period within each anniversary of the effective date of the license that minimum annual license fee must be paid     60 days    
Maximum total milestone payments       $ 1,550,000  
Period within which the milestone payments should be paid upon achievement of the milestone       60 days  
Enrollment of first patient in a phase II clinical trial of a therapeutic product or process       $ 100,000  
Enrollment of first patient in a phase III clinical trial of a therapeutic product or process       200,000  
First commercial sale of a therapeutic product or process       1,000,000  
Filing of an application for regulatory approval of a clinical diagnostic product or process       100,000  
First regulatory approval of a clinical diagnostic product or process       $ 150,000  
Royalties calculated as a percentage to on net sales of licensed products for therapeutic products or processes       3.00%  
Royalties calculated as a percentage to on net sales of licensed products for clinical diagnostic products and processes       6.00%  
Royalties calculated as a percentage of any and all sublicense income       30.00%  
Notice period for terminating License       90 days  
Period after the first commercial sale that the License shall continue if not terminated by the company       10 years  
Royalty percentage beyond the term of the License       1.50%  
Minimum annual license fee for Patent Family 1 $ 30,000 $ 25,000      
Minimum annual license fee related to Patent Family 2       $ 10,000  
Accrued license obligations       $ 14,868 $ 697